Apigenin induces apoptosis through a mitochondria/caspase-pathway in human breast cancer MDA-MB-453 cells

Journal of Clinical Biochemistry and Nutrition

Volumn 44, Issue 3, 2009, Pages 260-265

  Eun, Jeong Choi ^a   Kim, Gun Hee ^a  

^a Duksung Women's University   (South Korea)

Author keywords

Apigenin; Apoptosis; Caspases cascade; Human breast cancer MDA MB 453 cells

Indexed keywords

APIGENIN; CASPASE; CASPASE 3; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; CYTOCHROME C;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IC 50; MITOCHONDRION; PROTEIN CLEAVAGE; PROTEIN SECRETION; SIGNAL TRANSDUCTION;

EID: 68549088745     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.08-230     Document Type: Article

References (31)

1. Ren, W., Qiao, Z., Wang, H., Zhu, L., and Zhang, L.: Flavonoids: promising anticancer agents. Med. Res. Rev., 23, 519-534, 2003.
2. Manthey, J.A., Grohmann, K., and Guthrie, N.: Biological properties of citrus flavonoids pertaining to cancer and inflammation. Curr. Med. Chem., 8, 135-153, 2001.
3. Ramos, S.: Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. Nutr. Biochem., 18, 427-442, 2007.
4. Kale, A., Gawande, S., and Kotwal, S.: Cancer phytotherapeutics: role for flavonoids at the cellular level. Phytother. Res., 22, 567-577, 2008.
5. Miean, K.H. and Mohamed, S.: Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants. J. Agric. Food Chem., 49, 3106-3112, 2001.
6. Soares, R. and Azevedo, I.: Apigenin: is it a pro- or antiinflammatory agent? Am. J. Pathol., 168, 1762-1763, 2006.
7. Fuchs, J. and Milbradt, R.: Skin anti-inflammatory activity of apigenin-7-glucoside in rats. Arzneimittelforschung, 43, 370-372, 1993.
8. Singh, J.P., Selvendiran, K., Banu, S.M., and Padmavathi, R.: Protective role of Apigenin on the status of lipid peroxidation and antioxidant defense against hepatocarcinogenesis in Wistar albino rats. Phytomedicine, 11, 309-314, 2004.
9. Romanova, D., Vachalkova, A., Cipak, L., Ovesna, Z., and Rauko, P.: Study of antioxidant effect of apigenin, luteolin and quercetin by DNA protective method. Neoplasma, 48, 104-107, 2001.
10. Bektic, J., Guggenberger, R., Spengler, B., Christiffel, V., Pelzer, A., Berger, A.P., Ramoner, R., Bartsch, G., and Klocker, H.: The flavonoid apigenin inhibits the proliferation of prostatic stromal cells via the MAPK-pathway and cell-cycle arrest in G1/S. Maturitas., 55s, s37-s46, 2006.
11. Lindenmeyer, F., Li, H., Menashi, S., Soria, C., and Lu, H.: Apigenin acts on the tumor cell invasion process and regulates protease production. Nutr. Cancer, 39, 139-147, 2001.
12. Czeczot, H., Tuek, B., Kusztelak, J., Szymczyk, T., Dobrowolska, B., Glinkowska, G., Malinowski, J., and Strzelecka, H.: Isolation and studies of the mutagenic activity in the Ames test of flavonoids naturally occurring in medical herbs. Mutat. Res., 240, 209-216, 1990.
13. Fulda, S. and Debatin, K.M.: Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene, 25, 4798-4811, 2006.
14. Prados, J., Melguizo, C., Boulaiz, H., Marchal, J.A., and Aranega, A.: Cancer gene therapy: strategies and clinical trials. Cell Mol. Biol., 51, 23-36, 2005.
15. Kim, R.: Recent advances in understanding the cell death pathways activated by anticancer therapy. Cancer, 103, 1551-1560, 2005.
16. Philchenkov, A., Zavelevich, M., Kroczak, T.J., and Los, M.: Caspases and cancer: mechanisms of inactivation and new treatment modalities. Exp. Oncol., 26, 82-97, 2004.
17. Ramos, S.: Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J. Nutr. Biochem., 18, 427-442, 2007.
18. Gercel-Taylor, C., Feitelson, A.K., and Taylor, D.D.: Inhibitory effect of genistein and daidzein on ovarian cancer cell growth. Anticancer Res., 24, 795-800, 2004.
19. Hedlund, T.E., van Bokhoven, A., Johannes, W.U., Nordeen, S.K., and Ogden, L.G.: Prostatic fluid concentrations of isoflavonoids in soy consumers are sufficient to inhibit growth of benign and malignant prostatic epithelial cells in vitro. Prostate, 66, 557-566, 2006.
20. Rassi, C.M., Lieberherr, M., Chaumaz, G., Pointillart, A., and Cournot, G.: Down-regulation of osteoclast differentiation by daidzein via caspase 3. J. Bone Miner. Res., 17, 630-638, 2002.
21. Totta, P., Acconcia, F., Virgili, F., Cassidy, A., Weinberg, P.D., Rimbach, G., and Marino, M.: Daidzein-sulfate metabolites affect transcriptional and antiproliferative activities of estrogen receptor-beta in cultured human cancer cells. J. Nutr., 135, 2687-2693, 2005.
22. Choi, E.J. and Kim, G.H.: Apigenin causes G(2)/M arrest associated with the modulation of p21(Cip1) and Cdc2 and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells. J. Nutr. Biochem., in press, 2008.
23. Torkin, R., Lavoie, J.F., Kaplan, D.R., and Yeger, H.: Induction of caspase-dependent, p53-mediated apoptosis by apigenin in human neuroblastoma. Mol. Cancer Ther., 4, 1-11, 2005.
24. Abu-Yousif, A.O., Smith, K.A., Getsios, S., Green, K.J., Van Dross, R.T., and Pelling, J.C.: Enhancement of UVB-induced apoptosis by apigenin in human keratinocytes and organotypic keratinocyte cultures. Cancer Res., 68, 3057-3065, 2008.
25. Xu, L., Zhang, L., Bertucci, A.M., Pope, R.M., and Datta, S.K.: Apigenin, a dietary flavonoid, sensitizes human T cells for activation-induced cell death by inhibiting PKB/Akt and NF-kappaB activation pathway. Immunol Lett., Epub ahead of print, 2008.
26. Zhang, Q., Zhao, X.H., and Wang, Z.J.: Flavones and flavonols exert cytotoxic effects on a human oesophageal adenocarcinoma cell line (OE33) by causing G2/M arrest and inducing apoptosis. Food Chem. Toxicol., 46, 2042-2053, 2008.
27. Wang, W., Heideman, L., Chung, C.S., Pelling, J.C., Koehler, K.J., and Birt, D.F.: Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines. Mol. Carcinog., 28, 102-110, 2002.
28. Kruidering, M. and Evan, G.I.: Caspase-8 in apoptosis: the beginning of "the end"? IUBMB Life, 50, 85-90, 2000.
29. Kim, P.K., Mahidhara, R., and Seol, D.W.: The role of caspase-8 in resistance to cancer chemotherapy. Drug resis. Updates, 4, 293-296, 2001.
30. Philchenkov, A., Zavelevich, M., Kroczak, T.J., and Los, M.: Caspases and cancer: mechanisms of inactivation and new treatment modalities. Exp. Oncol., 26, 82-97, 2004.
31. Kim, R.: Recent advances in understanding the cell death pathways activated by anticancer therapy. Cancer, 103, 1551-1560, 2005.